Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Plasma Glycosaminoglycans as Diagnostic and Prognostic Biomarkers in Surgically Treated Renal Cell Carcinoma

NCT03471897 is registered in ClinicalTrials.gov with Chalmers University of Technology as lead sponsor.

NCT NCT03471897
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03471897 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Plasma Glycosaminoglycans as Diagnostic and Prognostic Biomarkers in Surgically Treated Renal Cell Carcinoma
Lead sponsor
Chalmers University of Technology
Phase
Observational
Overall status
Completed
Start date
April 28, 2016
Completion date
January 18, 2018
Enrollment
237 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

renal cell carcinoma